GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » USMD Holdings Inc (NAS:USMD) » Definitions » EV-to-EBITDA

USMD Holdings (USMD Holdings) EV-to-EBITDA : -24.49 (As of Jun. 17, 2024)


View and export this data going back to 2012. Start your Free Trial

What is USMD Holdings EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, USMD Holdings's enterprise value is $258.0 Mil. USMD Holdings's EBITDA for the trailing twelve months (TTM) ended in Jun. 2016 was $-10.5 Mil. Therefore, USMD Holdings's EV-to-EBITDA for today is -24.49.

The historical rank and industry rank for USMD Holdings's EV-to-EBITDA or its related term are showing as below:

USMD's EV-to-EBITDA is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 12.64
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-17), USMD Holdings's stock price is $22.64. USMD Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2016 was $-0.090. Therefore, USMD Holdings's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


USMD Holdings EV-to-EBITDA Historical Data

The historical data trend for USMD Holdings's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

USMD Holdings EV-to-EBITDA Chart

USMD Holdings Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
EV-to-EBITDA
Get a 7-Day Free Trial - 6.35 21.66 -6.56 -14.64

USMD Holdings Quarterly Data
Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.92 -4.65 -14.64 -23.84 -23.85

Competitive Comparison of USMD Holdings's EV-to-EBITDA

For the Medical Care Facilities subindustry, USMD Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


USMD Holdings's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, USMD Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where USMD Holdings's EV-to-EBITDA falls into.



USMD Holdings EV-to-EBITDA Calculation

USMD Holdings's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=257.960/-10.533
=-24.49

USMD Holdings's current Enterprise Value is $258.0 Mil.
USMD Holdings's EBITDA for the trailing twelve months (TTM) ended in Jun. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


USMD Holdings  (NAS:USMD) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

USMD Holdings's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=22.64/-0.090
=At Loss

USMD Holdings's share price for today is $22.64.
USMD Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.090.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


USMD Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of USMD Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


USMD Holdings (USMD Holdings) Business Description

Traded in Other Exchanges
N/A
Address
USMD Holdings Inc is a Delaware corporation formed on May 7, 2010. The Company is a health care management company. It provides healthcare services to patients and management and operational services to hospitals and other healthcare service providers. The Company provides healthcare services to patients in physician clinics, hospitals and other healthcare facilities, including cancer treatment centers and anatomical pathology and clinical laboratories. A wholly owned subsidiary of the Company is the sole member of a Texas Certified Non-Profit Health Organization that owns and operates a multi-specialty physician group practice (USMD Physician Services) in the Dallas-Fort Worth, Texas metropolitan area. Through other wholly owned subsidiaries, the Company provides management and operational services to two short-stay hospitals in the Dallas-Fort Worth, Texas metropolitan area and provides management and/or operational services to three cancer treatment centers in three states and 22 lithotripsy service providers (i.e., kidney stone treatment) located in the South-Central United States. Of these managed entities, the Company has limited ownership interests in the two hospitals, two cancer treatment centers and 20 lithotripsy service providers. In addition, the Company wholly owns and operates two clinical laboratories, one anatomical pathology laboratory, one cancer treatment center and two lithotripsy service providers in the Dallas-Fort Worth, Texas metropolitan area. The Company operates in one physician-led integrated health system segment. It competes for patients with other integrated health systems, physician practices, hospitals, outpatient surgery centers, diagnostic facilities and other free-standing facilities.
Executives
Breaux Castleman director 7 TECHNOLOGY DRIVE, IRVINE CA 92618

USMD Holdings (USMD Holdings) Headlines

No Headlines